World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: CTRI
Last refreshed on: 24 November 2021
Main ID:  CTRI/2016/01/006574
Date of registration: 28-01-2016
Prospective Registration: Yes
Primary sponsor: Barkha Bindu
Public title: Effect of avoidance of nitrous oxide during anaesthesia in patients undergoing brain tumour surgery.
Scientific title: The effect of sevoflurane-air versus sevoflurane-nitrous oxide anaesthesia on length of ICU and hospital stay in patients undergoing cerebellopontine tumour surgery- a randomised controlled trial.
Date of first enrolment: 01-03-2016
Target sample size: 50
Recruitment status: Completed
URL:  http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=13123
Study type:  Interventional
Study design:  Randomized, Parallel Group, Active Controlled Trial
Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant Blinded
 
Phase:  N/A
Countries of recruitment
India
Contacts
Name: Mihir Prakash Pandia   
Address:  Room No. 709 Dept. of Neuroanaesthesia Neurosciences Centre AIIMS, New Delhi 110029 South West, DELHI India
Telephone:
Email: pandiamihir@gmail.com
Affiliation:  AIIMS
Name: Mihir Prakash Pandia   
Address:  Room No. 709 Dept. of Neuroanaesthesia Neurosciences Centre AIIMS, New Delhi 110029 South West, DELHI India
Telephone:
Email: pandiamihir@gmail.com
Affiliation:  AIIMS
Key inclusion & exclusion criteria
Inclusion criteria: ASA grade I & II patients.

Patients of cerebellopontine angle tumours posted for elective tumour excision surgery.

Anticipated duration of anaesthesia more than 6 hours.


Exclusion criteria: Refusal of consent.

Patients with history of smoking.

Haemodynamically unstable patients.

Hb < 8gm%.

Evidence of pneumocephalus on CT scan.

Patients with evidence of pneumothorax.

Patients with bleeding disorders.

Patients with preoperative GCS <15.

Patients with significant pulmonary disease, renal or hepatic disorders, unstable angina, uncontrolled diabetes or hypertension.

Pregnant females.

Patients operated upon in sitting position.

Patients with BMI > 35.



Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Health Condition 1: null- Cerebellopontine angle tumours
Intervention(s)
Intervention1: Nitrous Oxide: Nitrous Oxide with Oxygen (FiO2 0.4) with Sevoflurane
Control Intervention1: Nitrous oxide: Nitrous oxide with Oxygen (FiO2 0.4) with Sevoflurane
Primary Outcome(s)
To compare the mean duration of ICU stay and hospital stay.Timepoint: At time of discharge from ICU and at time of discharge from hospital
Secondary Outcome(s)
1. To compare intraoperative brain condition, emergence, duration of postoperative ventilation and GOS at discharge.

2. To compare the incidence of hemodynamic fluctuations and complications in the intraoperative and postoperative period.

Timepoint: 1. During surgery and post operative period

2. During surgery and post operative period
Secondary ID(s)
NIL
Source(s) of Monetary Support
All India Institute of Medical Sciences, New Delhi
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 27/11/2015
Contact:
Institute Ethics Committee for Post Graduate Research, AIIMS
Results
Results available:
Date Posted:
Date Completed: 30/03/2017
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history